Application of triple evaluation method in predicting the efficacy of neoadjuvant therapy for breast cancer

Table 4 Consistency analysis of triple evaluation method and pathological gold standard

Clinical efficacy discrimination × two pathological classifications cross table
Count
		Two pathological classifications			Total
			0	1	Total
Clinical efficacy discrimination		69	0	0	69
	2	0	0	5	5
	1	0	24	3	27
	0	0	109	2	111
Total		69	133	10	212
Symmetry measurement
		Value	Asymptotic standard error^a	Approximate T^b	Gradual significance
Protocol measurement	Kappa	.716	.039	14.059	.000
Number of valid cases		212

ISSN: 1477-7819